Clinical Trial

Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).

Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated April 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this clinical trial is to assess preemptive oral pregabalin administration in the obese patients undergoing laparoscopic sleeve gastrectomy. The main aims of the study are to evaluate postoperative pain treatment and effect on the intraoperative hemodynamical stability. The participants will be divided into 2 groups: with or without preemptive pregabalin administration.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05804591
Lead Sponsor Medical University of Warsaw
Conditions Obesity, Postoperative Pain, Postoperative Nausea and Vomiting, Opioid Use
Enrollment 90 participants
Start Date 2023-04-24
Primary Completion 2025-04-01 (estimated)
Study Completion 2025-08-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-19